A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinomaL. GoyalD. DiToroet al.2025Annals of Oncology
Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to sacituzumab govitecan in triple-negative breast cancerJames T. CoatesSheng Sunet al.2021Cancer Discovery